Glydo Jelly
Product Images NDC 25021-673

6 FDA label images from Sagent Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Glydo (NDC 25021-673). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sagent Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Lid09 0014 01)

Figure (Lid09 0014 01)
Chemical structure diagram of lidocaine hydrochloride, showing the molecular arrangement with a benzene ring substituted by methyl groups, an amide linkage, and diethylamino groups bound to hydrochloride.*
FDA Label Image

Figure (Lid09 0014 02)

Figure (Lid09 0014 02)
A black and white instructional diagram showing two hands preparing a syringe-like applicator. One hand holds the barrel and plunger of the device while the other hand is removing the tip cap from the applicator tip.*
FDA Label Image

Figure (Lid09 0014 03)

Figure (Lid09 0014 03)
An instructional illustration showing two hands, one holding a tube of medication while the other removes the cap, likely demonstrating how to open a tube of topical jelly. One hand is gloved, indicating a medical or sterile context.*
FDA Label Image

Figure (Lid09 0014 04)

Figure (Lid09 0014 04)
Instructional illustration showing the topical application of glydo (lidocaine hydrochloride) 20 mg/mL jelly for male and female anatomy. The male section depicts insertion of jelly into the urethra using a syringe. The female section shows similar urethral application via syringe on external female genitalia. The images guide correct dosing technique for each sex.*
FDA Label Image

Package Label – Principal Display Panel – Syringe Label (Lid09 0014 05)

Package Label – Principal Display Panel – Syringe Label (Lid09 0014 05)
Label for Glydo (lidocaine hydrochloride) 2% jelly, 20 mg/mL strength, in a 6 mL single-dose prefilled topical syringe. The product is a sterile anesthetic, preservative-free, manufactured for Sagent Pharmaceuticals by Klosterfrau Berlin GmbH in Germany. The label includes dosing instructions, storage conditions, barcode, lot, and expiration placeholders.*
FDA Label Image

Package Label – Principal Display Panel – Syringe Label (Lid09 0014 06)

Package Label – Principal Display Panel – Syringe Label (Lid09 0014 06)
Label for Glydo lidocaine hydrochloride jelly 20 mg/mL (2%), an 11 mL single-dose prefilled syringe for topical use. The label states it is a sterile topical anesthetic, preservative-free, and provides storage instructions. Manufactured by Klosterfrau Berlin GmbH for Sagent Pharmaceuticals in Germany.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.